Literature DB >> 19223647

Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa.

Renata Cristina Picão, Laurent Poirel, Ana C Gales, Patrice Nordmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223647      PMCID: PMC2681545          DOI: 10.1128/AAC.01602-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.

Authors:  L Poirel; I Le Thomas; T Naas; A Karim; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

Review 2.  Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact.

Authors:  Gerhard F Weldhagen; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

3.  A CTX-M extended-spectrum beta-lactamase in Pseudomonas aeruginosa and Stenotrophomonas maltophilia.

Authors:  Nashwan Al Naiemi; Birgitta Duim; Aldert Bart
Journal:  J Med Microbiol       Date:  2006-11       Impact factor: 2.472

Review 4.  Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.

Authors:  Johann D D Pitout; Kevin B Laupland
Journal:  Lancet Infect Dis       Date:  2008-03       Impact factor: 25.071

Review 5.  Genetic support of extended-spectrum beta-lactamases.

Authors:  L Poirel; T Naas; P Nordmann
Journal:  Clin Microbiol Infect       Date:  2008-01       Impact factor: 8.067

6.  Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli.

Authors:  T Kieser
Journal:  Plasmid       Date:  1984-07       Impact factor: 3.466

Review 7.  Clinically significant carbapenemases: an update.

Authors:  Timothy R Walsh
Journal:  Curr Opin Infect Dis       Date:  2008-08       Impact factor: 4.915

8.  Spread of bla(CTX-M-type) and bla(PER-2) beta-lactamase genes in clinical isolates from Bolivian hospitals.

Authors:  Giuseppe Celenza; Cristina Pellegrini; Marisa Caccamo; Bernardetta Segatore; Gianfranco Amicosante; Mariagrazia Perilli
Journal:  J Antimicrob Chemother       Date:  2006-03-01       Impact factor: 5.790

9.  Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.

Authors:  Ana C Gales; Liana C Menezes; Suzane Silbert; Hélio S Sader
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

  9 in total
  13 in total

1.  Resistance to broad-spectrum antibiotics in aquatic systems: anthropogenic activities modulate the dissemination of bla(CTX-M)-like genes.

Authors:  Marta Tacão; António Correia; Isabel Henriques
Journal:  Appl Environ Microbiol       Date:  2012-04-06       Impact factor: 4.792

2.  BEL-2, an extended-spectrum beta-lactamase with increased activity toward expanded-spectrum cephalosporins in Pseudomonas aeruginosa.

Authors:  Laurent Poirel; Jean-Denis Docquier; Filomena De Luca; Annemie Verlinde; Louis Ide; Gian Maria Rossolini; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

3.  Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.

Authors:  Renata C Picão; Laurent Poirel; Ana C Gales; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2009-07-13       Impact factor: 5.191

4.  Efflux pumps expression and its association with porin down-regulation and beta-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil.

Authors:  Danilo E Xavier; Renata C Picão; Raquel Girardello; Lorena C C Fehlberg; Ana C Gales
Journal:  BMC Microbiol       Date:  2010-08-12       Impact factor: 3.605

Review 5.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

6.  Pseudomonas aeruginosa: resistance to the max.

Authors:  Keith Poole
Journal:  Front Microbiol       Date:  2011-04-05       Impact factor: 5.640

7.  CTX-M Enzymes: Origin and Diffusion.

Authors:  Rafael Cantón; José María González-Alba; Juan Carlos Galán
Journal:  Front Microbiol       Date:  2012-04-02       Impact factor: 5.640

8.  Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.

Authors:  Asma Tchakal-Mesbahi; Merzak Metref; Vijay K Singh; Marianna Almpani; Laurence G Rahme
Journal:  Burns       Date:  2021-03-17       Impact factor: 2.744

Review 9.  Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.

Authors:  Mariana Castanheira; Patricia J Simner; Patricia A Bradford
Journal:  JAC Antimicrob Resist       Date:  2021-07-16

10.  Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.

Authors:  Milena Polotto; Tiago Casella; Maria Gabriela de Lucca Oliveira; Fernando G Rúbio; Mauricio L Nogueira; Margarete Tg de Almeida; Mara Cl Nogueira
Journal:  BMC Infect Dis       Date:  2012-08-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.